MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy.

Yong TianJunhong WangYanxiao LiuXiangguang LuoZiying YaoXinjun WangYuanyuan ZhangCheng XuXiaoyu Zhao

Published in: BMC medical genomics (2021)

Gene polymorphisms related to pharmacotherapy were common in Chinese T2DM patients. And the expression of LDL-C and sdLDL-C was consistent with the T2DM disease course. Combined multigene screening before therapy and LDL-C and sdLDL-C detection before and after therapy could better assist T2DM treatment.

Keyphrases

poor prognosis
newly diagnosed
loop mediated isothermal amplification
type diabetes
stem cells
prognostic factors
smoking cessation
cell therapy
metabolic syndrome
binding protein
long non coding rna
combination therapy
quantum dots